🇺🇸 Low-dose furosemide combined with low-dose dopamine in United States

Low-dose furosemide combined with low-dose dopamine (Low-dose furosemide combined with low-dose dopamine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Low-dose furosemide combined with low-dose dopamine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Low-dose furosemide combined with low-dose dopamine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Low-dose furosemide combined with low-dose dopamine in United States?

Larissa University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.